Literature DB >> 29463102

Social and behavioral factors associated with failing second-line ART - results from a cohort study at the Themba Lethu Clinic, Johannesburg, South Africa.

Denise Evans1, Sara Dahlberg2, Rebecca Berhanu3, Tembeka Sineke1, Caroline Govathson1, Ingrid Jonker3, Elisabet Lönnermark2, Matthew P Fox4,5.   

Abstract

Poor adherence is a main challenge to successful second-line ART in South Africa. Studies have shown that patients can re-suppress their viral load following intensive adherence counselling. We identify factors associated with failure to re-suppress on second-line ART. The study was a retrospective cohort study which included HIV-positive adults who experienced an elevated viral load ≥400 copies/ml on second-line ART between January 2013-July 2014, had completed an adherence counselling questionnaire and had a repeat viral load result recorded within 6 months of intensive adherence counselling. Log-binomial regression was used to evaluate the association between patient characteristics and social, behavioral or occupational factors and failure to suppress viral load (≥400 copies/ml). A total of 128 patients were included in the analysis, and of these 39% (n = 50) failed to re-suppress their viral load. Compared to those who suppressed, far more patients who failed to suppress reported living with family (44.2% vs. 23.7%), missing a dose in the past week (53.3% vs. 30.0%), using traditional/herbal medications (63.2% vs. 34.3%) or had symptoms suggestive of depression (57.7% vs. 34.3%). These patient-related factors could be targeted for interventions to reduce the risk for treatment failure and prevent switching to expensive third-line ART.

Entities:  

Keywords:  intensive adherence counselling; resource limited setting; second-line antiretroviral therapy; viral suppression; virologic failure

Mesh:

Substances:

Year:  2018        PMID: 29463102      PMCID: PMC7317067          DOI: 10.1080/09540121.2017.1417527

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  22 in total

1.  HIV drug resistance mutations among patients failing second-line antiretroviral therapy in Rwanda.

Authors:  Jean d'Amour Ndahimana; David J Riedel; Ribakare Muhayimpundu; Sabin Nsanzimana; Gad Niyibizi; Emmanuel Mutaganzwa; Augustin Mulindabigwi; Cyprien Baribwira; Athanase Kiromera; Linda L Jagodzinski; Sheila A Peel; Robert R Redfield
Journal:  Antivir Ther       Date:  2015-11-12

2.  Discontinuation and modification of highly active antiretroviral therapy in HIV-infected Ugandans: prevalence and associated factors.

Authors:  Ronald Kiguba; Jayne Byakika-Tusiime; Charles Karamagi; Francis Ssali; Peter Mugyenyi; Elly Katabira
Journal:  J Acquir Immune Defic Syndr       Date:  2007-06-01       Impact factor: 3.731

Review 3.  Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis.

Authors:  Olawale Ajose; Siddharth Mookerjee; Edward J Mills; Andrew Boulle; Nathan Ford
Journal:  AIDS       Date:  2012-05-15       Impact factor: 4.177

4.  Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis.

Authors:  Mark A Boyd; Cecilia L Moore; Jean-Michel Molina; Robin Wood; Juan S Madero; Marcelo Wolff; Kiat Ruxrungtham; Marcelo Losso; Boris Renjifo; Hedy Teppler; Anthony D Kelleher; Janaki Amin; Sean Emery; David A Cooper
Journal:  Lancet HIV       Date:  2015-01-20       Impact factor: 12.767

5.  Antiretrovirals and the use of traditional, complementary and alternative medicine by HIV patients in Kwazulu-Natal, South Africa: a longitudinal study.

Authors:  Karl Peltzer; Natalie Friend-du Preez; Shandir Ramlagan; Henry Fomundam; Jane Anderson; Lucia Chanetsa
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-06-01

6.  Medication adherence for HIV positive women caring for children: in their own words.

Authors:  S A Wood; C Tobias; J McCree
Journal:  AIDS Care       Date:  2004-10

7.  High rates of survival, immune reconstitution, and virologic suppression on second-line antiretroviral therapy in South Africa.

Authors:  Matthew P Fox; Prudence Ive; Lawrence Long; Mhairi Maskew; Ian Sanne
Journal:  J Acquir Immune Defic Syndr       Date:  2010-04-01       Impact factor: 3.731

8.  Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study.

Authors:  M Martin; E Del Cacho; C Codina; M Tuset; E De Lazzari; J Mallolas; J-M Miró; J M Gatell; J Ribas
Journal:  AIDS Res Hum Retroviruses       Date:  2008-10       Impact factor: 2.205

9.  Changes in second-line regimen durability and continuity of care in relation to national ART guideline changes in South Africa.

Authors:  Dorina Onoya; Alana T Brennan; Rebecca Berhanu; Liudmyla van der Berg; Thulasizwe Buthelezi; Matthew P Fox
Journal:  J Int AIDS Soc       Date:  2016-12-22       Impact factor: 5.396

10.  Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India.

Authors:  Samsuddin Khan; Mrinalini Das; Aristomo Andries; Alaka Deshpande; Homa Mansoor; Peter Saranchuk; Petros Isaakidis
Journal:  Glob Health Action       Date:  2014-07-30       Impact factor: 2.640

View more
  3 in total

1.  Treatment modification after second-line failure among people living with HIV in the Asia-Pacific.

Authors:  Awachana Jiamsakul; Iskandar Azwa; Fujie Zhang; Evy Yunihastuti; Rossana Ditangco; Nagalingeswaran Kumarasamy; Oon Tek Ng; Yu-Jiun Chan; Penh Sun Ly; Jun Yong Choi; Man-Po Lee; Sanjay Pujari; Sasisopin Kiertiburanakul; Romanee Chaiwarith; Tuti Parwati Merati; Shashikala Sangle; Suwimon Khusuwan; Benedict Lh Sim; Anchalee Avihingsanon; Cuong Duy; Junko Tanuma; Jeremy Ross; Matthew Law; Treat Asia Hiv Observational Database Of IeDEA Asia-Pacific
Journal:  Antivir Ther       Date:  2020

2.  Second line anti-retroviral therapy failure in a pediatric cohort of an Ethiopian tertiary hospital: a retrospective observational study.

Authors:  Tinsae Alemayehu; Workeabeba Abebe
Journal:  Sci Rep       Date:  2020-05-26       Impact factor: 4.379

Review 3.  Potential challenges to sustained viral load suppression in the HIV treatment programme in South Africa: a narrative overview.

Authors:  Pascal O Bessong; Nontokozo D Matume; Denis M Tebit
Journal:  AIDS Res Ther       Date:  2021-01-06       Impact factor: 2.250

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.